NMRA — Neumora Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Neumora Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS/A	PROSPECTUS/A	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	409	372	454	308	183
Net Total Receivables	0.2	0.919	0.939	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	416	388	478	314	191
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.04	10.6	6.86	2.92	0.457
Long Term Investments
Other Long Term Assets
Total Assets	429	426	496	317	191
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	23.3	23.7	25.1	29.9	32.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	24.7	29.4	27.1	29.9	87.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	405	397	469	287	104
Total Liabilities & Shareholders' Equity	429	426	496	317	191
Total Common Shares Outstanding